Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321): clinical trials recruiting now
Fewer than 3 recruiting trials found.
1
Recruiting trials
2
Conditions studied
1
US states with sites
1
Countries
Phase breakdown
Phase 4 1
Conditions being studied
| Condition | Trials |
|---|---|
| Diabetic Macular Edema (DME) | 1 |
| Type 2 diabetes | 1 |
Recruiting trials involving Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)
Common questions
How many recruiting trials involve Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)?
1 recruiting trial across 2 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.